CRIS Current Research Information System

POTENA, LUCIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.047
NA - Nord America 5.995
EU - Europa 4.523
SA - Sud America 334
AF - Africa 319
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.246
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.920
SG - Singapore 1.664
VN - Vietnam 1.647
CN - Cina 1.498
IT - Italia 1.096
GB - Regno Unito 823
DE - Germania 615
SE - Svezia 570
HK - Hong Kong 392
FR - Francia 276
IN - India 255
BR - Brasile 244
UA - Ucraina 236
RU - Federazione Russa 190
IE - Irlanda 167
NL - Olanda 155
KR - Corea 136
JP - Giappone 121
FI - Finlandia 97
ZA - Sudafrica 91
TG - Togo 72
JO - Giordania 64
CI - Costa d'Avorio 63
BG - Bulgaria 59
EE - Estonia 49
CA - Canada 47
AT - Austria 44
PH - Filippine 43
AR - Argentina 41
CH - Svizzera 36
TH - Thailandia 34
NG - Nigeria 31
SC - Seychelles 31
BD - Bangladesh 28
TR - Turchia 22
AU - Australia 21
BE - Belgio 21
ES - Italia 21
ID - Indonesia 20
IQ - Iraq 19
IR - Iran 19
MX - Messico 18
PL - Polonia 17
TW - Taiwan 16
PK - Pakistan 15
CO - Colombia 11
LT - Lituania 11
SA - Arabia Saudita 11
EC - Ecuador 10
GR - Grecia 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 7
MA - Marocco 7
PY - Paraguay 7
DZ - Algeria 6
LB - Libano 6
UY - Uruguay 6
VE - Venezuela 6
AZ - Azerbaigian 5
CL - Cile 5
PT - Portogallo 5
RO - Romania 5
TN - Tunisia 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
EU - Europa 4
KE - Kenya 4
PE - Perù 4
SI - Slovenia 4
EG - Egitto 3
HU - Ungheria 3
MY - Malesia 3
AM - Armenia 2
CR - Costa Rica 2
CY - Cipro 2
FJ - Figi 2
JM - Giamaica 2
KG - Kirghizistan 2
SV - El Salvador 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
ET - Etiopia 1
GH - Ghana 1
KH - Cambogia 1
KZ - Kazakistan 1
LY - Libia 1
MC - Monaco 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 17.243
Salva come PNG Salva come JPEG
Città #
Singapore 1.178
Ashburn 709
Southend 682
Fairfield 465
Chandler 413
Houston 406
San Jose 388
Ho Chi Minh City 384
Hong Kong 376
Hanoi 364
Hefei 293
Santa Clara 254
Woodbridge 246
Wilmington 230
Seattle 220
Beijing 205
Bologna 202
Princeton 197
Cambridge 171
Dublin 167
Jacksonville 154
Boardman 153
Ann Arbor 136
Seoul 116
Lauterbourg 108
Tokyo 104
Los Angeles 101
New York 96
Milan 86
Bremen 85
Helsinki 73
Westminster 73
Lomé 72
Nanjing 70
Padova 70
Dong Ket 69
Amman 64
Abidjan 63
Berlin 63
Munich 63
Da Nang 61
Buffalo 58
Haiphong 58
Sofia 58
Turin 57
Dallas 53
Frankfurt am Main 50
Rome 49
Shenyang 44
Council Bluffs 43
Jinan 42
Mülheim 34
Medford 33
Bengaluru 32
Redmond 32
Saint Petersburg 32
Shanghai 31
Florence 30
Abeokuta 29
Changsha 29
São Paulo 29
Guangzhou 28
Hebei 28
Redondo Beach 28
Vienna 28
Johannesburg 25
Bern 24
Falkenstein 24
Hải Dương 24
San Diego 24
Biên Hòa 23
London 22
Tianjin 22
Zhengzhou 22
Nanchang 21
Jiaxing 20
Toronto 20
Brussels 18
Turku 18
Mahé 17
The Dalles 16
Yubileyny 16
Bangkok 15
Bắc Ninh 15
Orem 15
Stockholm 15
Thái Nguyên 15
Verona 15
Amsterdam 14
Can Tho 14
Chicago 14
Dearborn 14
Des Moines 14
Ha Long 14
Nuremberg 14
Warsaw 14
Xi'an 14
Olalla 13
Reggio Emilia 13
Shenzhen 13
Totale 10.976
Salva come PNG Salva come JPEG
Nome #
L'inibitore endogeno della eNOS , la dimetil-arginina simmetrica (ADMA), è un nuovo fattore di rischio di vasculopatia coronarica post trapianto di cuore ed è infulenzato dalla terapia con sirolimus. 419
Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection. 368
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 322
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 249
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 246
Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes 243
Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungle. 234
Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies 222
Heart Transplant and Hepato-Renal Dysfunction: The Model of End-Stage Liver Disease Excluding International Normalized Ratio as a Predictor of Postoperative Outcomes 210
New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis. 201
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 200
Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection 200
Identification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD Scintigraphy 199
Age and heart transplantation: results from a heart failure management unit. 195
Manifestations of health anxiety in patients with heart transplant 192
Diagnosi non invasiva di rigetto miocardico acuto: l'analisi armonica dell'ecg coadiuva la valutazione clinica 187
Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. 187
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 183
Correlations Between Cardiac Magnetic Resonance and Myocardial Histologic Findings in Fabry Disease 181
Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice. 181
Ischemic injury activates PTHrP and PTH1R expression in human ventricular cardiomyocytes. 181
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 181
Static and dynamic predictors of adverse events in patients with intermediate cardiopulmonary capacity referred for heart transplantation. 181
Influence of the MELD-XI (Model of End-Stage Liver Disease Excluding INR) on Heart Transplant Outcomes 177
Impact of Pre-Transplant Pulmonary Hypertension Grading on Early- to Long-Term Hemodynamics, Right Venticular Graft Function and Survival After Heart Transplantation 177
Relationship between psychiatric disorders and physical status during the course of a heart transplantation program: a prospective, longitudinal study. 176
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 176
Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics. 175
Clinical and Prognostic Correlates of pAMR Grading in Patients with Suspect Antibody Mediated Rejection 173
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 173
Candidacy for heart transplantation in adult congenital heart disease patients: A cohort study 172
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction 171
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 169
Qualità della vita e parametri clinico-strumentali nello scompenso cardiaco. 168
Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. 168
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 167
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset 165
Nitrates and Angina: an insight into arterial and venular involvement in blood flow regulation. 165
Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study. 162
Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathy 160
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 160
Ruolo dell'NT-proBNP nella stratificazione prognostica dei pazienti con scompenso cardiaco cronico. 159
Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issue 159
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients 158
Il rallentamento del flusso di perfusione coronarica valutato con il TIMI frame count è in grado di predire la mortalità a lungo termine nei pazienti con trapianto di cuore 157
Efficacia e sicurezza dell'ezetimibe in associazione con basse dosi di simvastatina per il trattamento dell'iperlipidemia post-trapianto cardiaco 156
La progressione della coronarografia del graft è proporzionale alla severità dell'infezione da citomegalovirus nei pazienti con trapianto cardiaco. 154
Prophylaxis vs. Pre-Emptive Strategies in Preventing Cytomegalovirus-Dependent Cardiac Allograft Vasculopathy 154
Identification and classification of acute cardiac rejection by intragraft transcriptional profiling. 154
Reproducibility of IVUS Measurements in Heart Transplant Recipients: Increased Quality of Data by Using Dedicated Software for Image Analysis 154
Predicting Right Ventricular Failure in the Current Continuous Flow Left Ventricular Assist Device Era 152
Comprehensive Non-invasive Versus Invasive Approach to Evaluate Cardiac Allograft Vasculopathy in Heart Transplantation: The CCTA-HTx Study 151
PRE-TRANSPLANT NON-CYTOTOXIC ANTI-HLA ANTIBODIES PREDICT MULTIPLE ADVERSE EVENTS AFTER HEART TRANSPLANTATION 151
Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study. 151
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 150
Pre-Transplant Non-Cytotoxic Anti-HLA Antibodies Predict Multiple Adverse Events after Heart Transplantation 149
Correlazione tra metodi semiquantitativi e quantitativi nella valutazione dell'insufficienza mitralica organica ed associazione con test da sforzo cardiopolmonare e pro-BNP 148
L'inibitore endogeno della eNOS favorisce la progressione dell'infezione da cytoomegalovirus e del rigetto miocardico acuto nei pazienti con trapianto di cuore. 145
Heart transplantation in hypertrophic cardiomyopathy. 145
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients? 143
Interplay between Pulmonary Hypertension and Donor-Recipient Matching in the Risk for Early Graft Failure after Heart Transplantation 143
L'infezione da citomegalovirus e i parametri indicativi di insulino-resistenza influenzano in modo distinto e specifico le variazioni nella geometria coronarica nel primo anno dopo trapianto di cuore 143
Viral genome search in myocardium of patients with fulminant myocarditis 141
Prevalence of substance-related disorders in heart transplantation candidates 140
Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors 139
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review 139
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 138
Clinical profile and in-hospital outcome of patients supported by intra-aortic balloon pump in the clinical setting of cardiogenic shock 138
Psychological predictors of mortality in heart transplanted patients: a prospective, 6-year follow-up study. 136
Relevance of cardioverter defibrillators for the prevention of sudden cardiac death on the timing of heart transplantation. 136
Long-term immune response after SARS-CoV2 vaccination in solid organ transplant recipients 135
SAFETY AND EFFICACY OF TWO TYPES OF INFLUENZA VACCINATION IN HEART TRANSPLANT RECIPIENTS: A PROSPECTIVE RANDOMISED CONTROLLED STUDY 135
Prolactin Inhibition to Treat Postpartum Arrhythmic Storm 134
Extracorporeal Membrane Oxygenation Support System as Bridge to Solution in Refractory Cardiogenic Shock 134
Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome 133
Insufficienza mitralica organica: parametri ecocardiografici, funzionali e neuro-ormonali potenziali predittori di intervento chirurgico a breve termine 133
Impact of Current Donor Scores Calculation on Heart Transplantation Outcomes 132
L'infezione subclinica da citomegalovirus modula l'infiammazione sistemica e il rimodellamento coronarico ad un anno dal trapianto. 131
Potential of medical treatment, device therapy, and conventional surgery in patients referred for heart transplantation. 131
Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients 130
Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions. 130
Cytomegalovirus infectious burden is proportional to cardiac allograft vasculopathy in heart transplant recipients 128
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 127
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians 127
Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients. 124
Impact of prior sternotomy on survival and allograft function after heart transplantation: A single center matched analysis 122
Donor-derived human herpesvirus 8 infection with Kaposi sarcoma and Kaposi sarcoma inflammatory cytokine syndrome in a heart transplant recipient: A case report 120
Role of Donor-Recipient Match in Determining the Risk for Primary Graft Failure after Heart Transplantation 118
Extracorporeal membrane oxygenation for the treatment of refractory cardiogenic shock in adults: strategies, results, and predictors of mortality = Sistemi di ossigenazione a membrana extracorporea come trattamento per lo shock cardiogeno refrattario nella popolazione adulta: strategie, risultati e predittori di mortalità 118
Studio prospettico randomizzato sull'effetto della terapia con acido folico nella preenzione della malattia coronarica nel paziente trapiantato 116
COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak 115
Donor risk analysis and validation in heart transplants: A single-centre experience 114
Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation. 112
Long-term effect of folic Acid therapy in heart transplant recipients: follow-up analysis of a randomized study. 111
Impact of Predicted Heart Mass–Based Donor-Recipient Size Matching on Transplant Outcomes 107
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 107
CTA-Derived Pericoronary Fat Attenuation Index Predicts Allograft Rejection and Cardiovascular Events in Heart Transplant Recipients 105
Study Design and Preliminary Results of the Italian Everolimus Registry CERTIC 102
Management of heart transplant candidates in the time of COVID-19 pandemic: Looking for answers 101
Evidence and current use of levosimendan in the treatment of heart failure: Filling the gap 100
Totale 16.131
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.604
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.604
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021362 0 0 0 0 0 0 0 0 0 68 46 248
2021/20221.601 66 51 108 214 132 70 41 121 65 149 322 262
2022/20232.110 192 269 109 256 182 189 55 114 379 86 193 86
2023/2024739 39 104 41 77 30 174 41 57 34 59 27 56
2024/20252.788 161 414 214 200 393 152 153 120 36 193 177 575
2025/20266.229 681 651 530 480 728 302 637 313 1.477 430 0 0
Totale 17.589